Email ID
Password
Forgotten your password?
Sign me in automatically next time
Advanced Search
Home
Companies
Patients
Investigators
Trials & Research
Regulatory
Therapeutics
Therapeutics
LATEST NEWS
Debiopharm inks deal with INC Research
26 July 2011
The CRO INC Research has formed a strategic partnership with Swiss biopharmaceutical company Debiopharm , which will see the CRO manage a clinical study for Debio 0932, while both have agreed a framework for INC's collaboration on future trials. INC Research will be firstly working on a trial for ...
Quotient works with MediGene to deliver on RhuDex clinical programme
21 June 2011
Quotient Clinical , a business unit of Quotient Bioresearch , has signed an agreement with the German biotechnology company MediGene , to undertake a formulation development and clinical testing programme on RhuDex, MediGene's candidate for rheumatoid arthritis, subject to ethical and MHRA ...
Lifetree CRO forms CNS partnership
02 March 2011
Public health policy consultants Pinney Associates and Lifetree Clinical Research , a specialised CRO, have formed a partnership programme that will allow the pharmaceutical industry access to clinical, regulatory, and post-marketing services for CNS drugs. This collaboration will provide clinical ...
START opens in China for cancer trials
31 January 2011
Clinical trial provider South Texas Accelerated Research Therapeutics (START) is to open START Shanghai, a joint venture between START and the China-based venture capital firm, Cenova Ventures . START Shanghai will be China's first oncology programme, created to provide patients with innovative ...
>> More Latest News...
FEATURES
A tale of two patients
08 October 2010
When David Hall felt his energy levels fall it was a surprise to him, but to be expected given his recent experiences. A man in his late seventies, he had been active and energetic all his life. However, he had been diagnosed with prostate cancer in 1998 and his wife had been diagnosed with ...
New ways to mend a broken heart
20 August 2009
The heart has always been a major focus of pharmaceutical research. This has produced wave after wave of new revenue streams with therapies that have transformed medical practice and prolonged millions of lives. By 2008, worldwide cardiovascular (CV) sales of US$79.3 billion were second only to ...
>> More Features...
PEOPLE
Biotec hires project managers to support growth
The clinical trials supply company Biotec Services International , has appointed two new project managers to strengthen the company’s expanding team. Clare Aubrey and Nicola Jenkins have been tasked with dealing with the increasing number of studies which are being undertaken by Biotec, which will ...
PharmaNet's Maida joins OncoSec board
OncoSec Medical , a therapeutic oncology company developing its advanced-stage ElectroOncology therapies to treat solid tumour cancers, has appointed Dr Anthony Maida to its board of directors and chair of its audit committee. Dr Maida was most recently vice-president of clinical research and ...
CRO veteran joins Waife & Associates
Waife & Associates , change management consultants in clinical research, has appointed Mark Di Ianni , of MDI Consulting Services , to head up its service provider management practice. Di Ianni has been a senior executive in the CRO industry for 30 years, founding and/or managing a series of ...
>> More People...
COMMENTARY
Portfolio strategies for maximum effect
If your company is fortunate enough to have multiple projects in your development pipeline, and assuming that you do not have an unlimited resource pool, then you will be faced with some critical choices as to which projects to support and which projects not to support. Support of a project ...
ICH-GCP: older but perhaps not wiser
The ICH Harmonised Tripartite Guideline for Good Clinical Practice E6(R1), to give it its full name, was adopted in Europe in 1996 (and in the US and Japan the following year). The aim of ICH-GCP is to provide a unified standard for the EU, the US and Japan to facilitate the mutual acceptance of ...
Breathing new life into the COPD market
Chronic obstructive pulmonary disease (COPD) is an umbrella term that refers to chronic lung diseases that share the common feature of restricted airflow. According to the most recent estimates from the WHO, there are currently 210 million COPD patients worldwide, of whom 80 million have moderate ...
Prevention is better than cure
Safety concerns are never far from view where pharmaceutical R&D is concerned. Early pre-clinical testing helps to determine whether a new substance is likely to cause serious adverse events in humans, and whether it should be progressed to clinical trials. While this has been the case for many ...
Excellence in site identification begins at home
We are all aware of a sponsor’s requirement to select investigators who are, as it states in the US Code of Federal Regulations, "qualified by training and experience as appropriate experts to investigate the drug" 1 in accordance with good clinical practices. However, the current competitive ...
Acne market fails to excite
Acne, the scourge of teenagers, is a chronic condition associated with blockage of the pilosebaceous ducts typically on the face, chest and back. The blockage is manifested as a comedo or ‘blackhead’ – the pigmentation is caused by melanin arising from the hair. In cases with more severe blockage ...
>> More Commentary...
About Us
Getting Started
Subscribe
FREE Trial
Advertise
Awards
White Papers
EVENTS
Expecting data for this section.
